Special Edition I October 2016 ACIP Meeting
- CDC Recommends Two HPV Shots for Younger Adolescents
- Talking to Patients and Their Parents about HPV Vaccination and Reduced Dosing
CDC now routinely recommends two doses of HPV vaccine for 11 or 12 year olds to prevent HPV cancers. This recommendation makes it easier for parents to protect their children by reducing the number of shots and trips to the doctor. HPV vaccination is an important cancer prevention tool and two doses of HPV vaccine will provide safe, effective and long-lasting protection when given at the recommended ages of 11 and 12 years. Some of the specifics of the recommendation include:
- The first HPV vaccine dose is routinely recommended at 11-12 years old. The second dose of the vaccine should be administered 6 to 12 months after the first dose.
- Teens and young adults who start the series at ages 15 through 26 years will continue to need three doses of HPV vaccine to protect against cancer-causing HPV infections.
- Adolescents aged 9 through 14 years who have already received two doses of HPV vaccine less than 6 months apart, will require a third dose.
- Three doses are recommended for people with weakened immune systems aged 9-26 years.
With patients aged 11-12 years, start the vaccine discussion with their parents by making the following recommendation: “Now that your child is 11 (or 12) years old, they are due for three vaccines today to help protect them from meningitis, HPV cancers, and pertussis—or whooping cough.”
Many parents are accepting of this bundled recommendation because it demonstrates that HPV vaccination is a normal part of adolescent vaccination. Parents may be interested in vaccinating, yet still have questions. Some parents might just need additional information from you, the clinician they trust. Clarify what the parent’s question is or what additional information they need.
- For parents who have a question or need more information about “why now/why 11-12?” you can tell parents:
“Like with all vaccine-preventable diseases, we want to protect your child early. If we start now, it’s one less thing for you to worry about. Also, your child will only need two doses of HPV vaccine at this age. If you wait, your child may need three doses in order to get complete protection.
We’ll give the first shot today and then you’ll need to bring your child back in 6 to 12 months from now for the second dose.”
- If a parent has a question or needs more information about “How long can we wait and still give just two doses?” you can say:
“The second dose would have to be given before the 15th birthday, which means the first dose would need to be given before age 14, in order to get both doses in time.
However, I don’t recommend waiting to give this cancer-preventing vaccine. As children get older and have busier schedules, it becomes more difficult to get them back in. I’d feel best if we started the series today to get them protected as soon as possible.”
- For patients aged 9-14 who have already had two doses given less than 6 months apart, you can tell parents:
“In order for the new 2-dose schedule to provide protection the second dose needs to be given at least 6 months after the first dose. Because your child already started the HPV vaccine series and received the first two doses less than six months apart, we’ll need to give a third dose.”
- For parents who ask about the duration of protection or how well the vaccine will work with just two doses, you can say:
"Studies have shown that 2-doses of HPV vaccine work very well in younger adolescents and we expect the same long-lasting protection with 2 doses that we expect with 3 doses."
You can always access additional guidance on answering parents question about HPV vaccine by using our “tip sheet.”
Webinar on HPV Vaccine Recommendations Update on Oct 26 at Noon ET
CDC’s Immunization Services Division will be hosting a Current Issues in Immunization NetConference on October 26th from 12pm-1pm Eastern. Dr. Lauri Markowitz of the Division of Viral Diseases (NCIRD) will be discussing the HPV vaccine recommendation changes that occurred during the October ACIP meeting. Her presentation is entitled: “Recommendation for HPV Vaccination: 2016 Update.”
If you are unable to participate in the NetConference, it will be posted on CDC’s Current Issues in Immunization websiteafter November 1st. CE credits will continue to be available for 30 days.
Registration is now open!
Follow Dr. Messonnier's Twitter accountfor the latest information and news on immunizations, outbreaks, and NCIRD research.